vs
科睿唯安（CLVT）与SBA Communications（SBAC）财务数据对比。点击上方公司名可切换其他公司
SBA Communications的季度营收约是科睿唯安的1.2倍（$719.6M vs $617.0M），SBA Communications净利率更高（51.5% vs 0.5%，领先51.0%），SBA Communications同比增速更快（3.7% vs -6.9%），SBA Communications自由现金流更多（$833.3M vs $89.2M），过去两年SBA Communications的营收复合增速更高（4.6% vs -0.3%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
SBA Communications是一家房地产投资信托企业，核心业务为持有、运营无线通信基础设施，市场覆盖美国、加拿大、中南美洲及南非地区。公司由Steven Bernstein于1989年创立，前身为Steven Bernstein and Associates。
CLVT vs SBAC — 直观对比
营收规模更大
SBAC
是对方的1.2倍
$617.0M
营收增速更快
SBAC
高出10.7%
-6.9%
净利率更高
SBAC
高出51.0%
0.5%
自由现金流更多
SBAC
多$744.1M
$89.2M
两年增速更快
SBAC
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $617.0M | $719.6M |
| 净利润 | $3.1M | $370.4M |
| 毛利率 | 66.8% | 75.6% |
| 营业利润率 | 6.7% | 41.5% |
| 净利率 | 0.5% | 51.5% |
| 营收同比 | -6.9% | 3.7% |
| 净利润同比 | 101.6% | 107.2% |
| 每股收益（稀释后） | $0.00 | $3.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTSBAC
| Q4 25 | $617.0M | $719.6M | ||
| Q3 25 | $623.1M | $732.3M | ||
| Q2 25 | $621.4M | $699.0M | ||
| Q1 25 | $593.7M | $664.2M | ||
| Q4 24 | $663.0M | $693.7M | ||
| Q3 24 | $622.2M | $667.6M | ||
| Q2 24 | $650.3M | $660.5M | ||
| Q1 24 | $621.2M | $657.9M |
净利润CLVTSBAC
| Q4 25 | $3.1M | $370.4M | ||
| Q3 25 | $-28.3M | $236.8M | ||
| Q2 25 | $-72.0M | $225.8M | ||
| Q1 25 | $-103.9M | $220.7M | ||
| Q4 24 | $-191.8M | $178.8M | ||
| Q3 24 | $-65.6M | $258.5M | ||
| Q2 24 | $-304.3M | $162.8M | ||
| Q1 24 | $-75.0M | $154.5M |
毛利率CLVTSBAC
| Q4 25 | 66.8% | 75.6% | ||
| Q3 25 | 65.0% | 74.1% | ||
| Q2 25 | 67.2% | 75.4% | ||
| Q1 25 | 65.1% | 76.9% | ||
| Q4 24 | 65.7% | 78.1% | ||
| Q3 24 | 66.2% | 77.5% | ||
| Q2 24 | 67.2% | 78.6% | ||
| Q1 24 | 64.9% | 79.0% |
营业利润率CLVTSBAC
| Q4 25 | 6.7% | 41.5% | ||
| Q3 25 | 7.1% | 51.1% | ||
| Q2 25 | 1.1% | 47.9% | ||
| Q1 25 | -3.5% | 50.4% | ||
| Q4 24 | -9.4% | 55.1% | ||
| Q3 24 | 3.5% | 56.3% | ||
| Q2 24 | -36.9% | 53.7% | ||
| Q1 24 | 0.8% | 49.2% |
净利率CLVTSBAC
| Q4 25 | 0.5% | 51.5% | ||
| Q3 25 | -4.5% | 32.3% | ||
| Q2 25 | -11.6% | 32.3% | ||
| Q1 25 | -17.5% | 33.2% | ||
| Q4 24 | -28.9% | 25.8% | ||
| Q3 24 | -10.5% | 38.7% | ||
| Q2 24 | -46.8% | 24.7% | ||
| Q1 24 | -12.1% | 23.5% |
每股收益（稀释后）CLVTSBAC
| Q4 25 | $0.00 | $3.47 | ||
| Q3 25 | $-0.04 | $2.20 | ||
| Q2 25 | $-0.11 | $2.09 | ||
| Q1 25 | $-0.15 | $2.04 | ||
| Q4 24 | $-0.27 | $1.61 | ||
| Q3 24 | $-0.09 | $2.40 | ||
| Q2 24 | $-0.46 | $1.51 | ||
| Q1 24 | $-0.14 | $1.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $329.2M | $271.2M |
| 总债务越低越好 | $4.3B | $12.9B |
| 股东权益账面价值 | $4.8B | $-4.9B |
| 总资产 | $11.1B | $11.6B |
| 负债/权益比越低杠杆越低 | 0.89× | — |
8季度趋势，按日历期对齐
现金及短期投资CLVTSBAC
| Q4 25 | $329.2M | $271.2M | ||
| Q3 25 | $318.7M | $431.1M | ||
| Q2 25 | $362.6M | $276.8M | ||
| Q1 25 | $354.0M | $702.2M | ||
| Q4 24 | $295.2M | $444.4M | ||
| Q3 24 | $388.5M | $202.6M | ||
| Q2 24 | $376.4M | $250.9M | ||
| Q1 24 | $361.8M | $241.9M |
总债务CLVTSBAC
| Q4 25 | $4.3B | $12.9B | ||
| Q3 25 | $4.4B | $12.7B | ||
| Q2 25 | $4.5B | $12.5B | ||
| Q1 25 | $4.5B | $12.4B | ||
| Q4 24 | $4.5B | $13.6B | ||
| Q3 24 | $4.6B | $12.3B | ||
| Q2 24 | $4.6B | $12.3B | ||
| Q1 24 | $4.6B | $12.4B |
股东权益CLVTSBAC
| Q4 25 | $4.8B | $-4.9B | ||
| Q3 25 | $4.9B | $-4.9B | ||
| Q2 25 | $5.0B | $-4.9B | ||
| Q1 25 | $5.0B | $-5.0B | ||
| Q4 24 | $5.1B | $-5.1B | ||
| Q3 24 | $5.5B | $-5.2B | ||
| Q2 24 | $5.6B | $-5.3B | ||
| Q1 24 | $5.9B | $-5.2B |
总资产CLVTSBAC
| Q4 25 | $11.1B | $11.6B | ||
| Q3 25 | $11.2B | $11.3B | ||
| Q2 25 | $11.4B | $10.8B | ||
| Q1 25 | $11.5B | $10.4B | ||
| Q4 24 | $11.5B | $11.4B | ||
| Q3 24 | $12.0B | $10.2B | ||
| Q2 24 | $12.1B | $9.8B | ||
| Q1 24 | $12.5B | $10.0B |
负债/权益比CLVTSBAC
| Q4 25 | 0.89× | — | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.79× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $159.9M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $89.2M | $833.3M |
| 自由现金流率自由现金流/营收 | 14.5% | 115.8% |
| 资本支出强度资本支出/营收 | 11.5% | 63.7% |
| 现金转化率经营现金流/净利润 | 51.58× | 3.49× |
| 过去12个月自由现金流最近4个季度 | $365.3M | $1.7B |
8季度趋势，按日历期对齐
经营现金流CLVTSBAC
| Q4 25 | $159.9M | $1.3B | ||
| Q3 25 | $181.1M | $318.0M | ||
| Q2 25 | $116.3M | $368.1M | ||
| Q1 25 | $171.2M | $301.2M | ||
| Q4 24 | $141.3M | $1.3B | ||
| Q3 24 | $202.9M | $304.7M | ||
| Q2 24 | $126.2M | $425.6M | ||
| Q1 24 | $176.2M | $294.5M |
自由现金流CLVTSBAC
| Q4 25 | $89.2M | $833.3M | ||
| Q3 25 | $115.5M | $258.0M | ||
| Q2 25 | $50.3M | $312.2M | ||
| Q1 25 | $110.3M | $255.0M | ||
| Q4 24 | $59.1M | $1.2B | ||
| Q3 24 | $126.3M | $239.9M | ||
| Q2 24 | $60.3M | $375.6M | ||
| Q1 24 | $111.8M | $236.6M |
自由现金流率CLVTSBAC
| Q4 25 | 14.5% | 115.8% | ||
| Q3 25 | 18.5% | 35.2% | ||
| Q2 25 | 8.1% | 44.7% | ||
| Q1 25 | 18.6% | 38.4% | ||
| Q4 24 | 8.9% | 179.9% | ||
| Q3 24 | 20.3% | 35.9% | ||
| Q2 24 | 9.3% | 56.9% | ||
| Q1 24 | 18.0% | 36.0% |
资本支出强度CLVTSBAC
| Q4 25 | 11.5% | 63.7% | ||
| Q3 25 | 10.5% | 8.2% | ||
| Q2 25 | 10.6% | 8.0% | ||
| Q1 25 | 10.3% | 7.0% | ||
| Q4 24 | 12.4% | 12.6% | ||
| Q3 24 | 12.3% | 9.7% | ||
| Q2 24 | 10.1% | 7.6% | ||
| Q1 24 | 10.4% | 8.8% |
现金转化率CLVTSBAC
| Q4 25 | 51.58× | 3.49× | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | 1.63× | ||
| Q1 25 | — | 1.36× | ||
| Q4 24 | — | 7.47× | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | — | 2.61× | ||
| Q1 24 | — | 1.91× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
SBAC
暂无分部数据
